SUPN R&D Expenses
Supernus Pharmaceuticals Inc · R&D Expenses
SUPN R&D Expenses
Latest reported$126.09Mperiod ending
SUPN R&D Expenses ($19.27M → $126.09M)
Annual R&D Expenses
High-resolution chart · PNG
SUPN r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 106,235,000 | |
| 108,796,000 | |
| 91,593,000 | |
| 74,552,000 | |
| 90,467,000 | |
| 75,961,000 | |
| 69,099,000 | |
| 89,209,000 | |
| 49,577,000 | |
| 42,791,000 | |
| 29,135,000 | |
| 19,586,000 | |
| 17,245,000 | |
| 23,517,000 | |
| 30,627,000 | |
| 35,149,000 | |
| 29,260,000 | |
| 30,463,000 | |
| 19,268,757 |